Relationship between tumor markers CEA and CA 15-3 and recurrence breast cancer | Semantic Scholar
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer. | Semantic Scholar
Layojat Nigeria - A tumor marker is a biomarker found in... | Facebook
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
Тumor markers - Авицена Лабораторија
Diagnostic Value of Multiple Tumor Markers for Patients with Esophageal Carcinoma | PLOS ONE
Trajectories of perioperative serum carcinoembryonic antigen and colorectal cancer outcome: A retrospective, multicenter longitudinal cohort study - Li - 2021 - Clinical and Translational Medicine - Wiley Online Library
The Role of Tumor Markers: Carcinoembryonic Antigen and Cancer Antigen 15-3 in Patients With Breast Cancer
Tumor Marker Tests | Cancer.Net
Clinical significance of serum miR-21 in breast cancer compared with CA153 and CEA
Frontiers | Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population
Frontiers | The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients
How Biospecimens Support Biomarkers Development?
An individual reference limit of the serum CEA-TPA-CA 15-3 tumor marke | CMAR
Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Full article: Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
Prognostic Impact of a Novel Tumor Marker and Inflammation Index for Patients With Non-small-cell Lung Cancer | Anticancer Research